MAPT and hippocampal atrophy: A follow‐up visit found plasma p‐tau181 was associated with PET‐measured cerebral tau (AUC = 83.08%–93.11%) and Aβ (AUC = 76.14%–88.09%) pathologies, and 1‐year cognitive decline and hippocampal atrophy.18